Eulexin
Eulexin Price range: $ 51,00 through $ 475,00
Back to products
Eurax Lotion
Eurax Lotion Price range: $ 3,00 through $ 15,00

Eurax

Price range: $ 49,00 through $ 187,00

Eurax is a highly effective topical medication primarily used to treat scabies and provide rapid relief from intense skin irritation. The active ingredient, crotamiton, works by eliminating the mites responsible for scabies while simultaneously calming persistent itching. This fast-acting formula is designed to soothe the skin for up to ten hours after a single application. Beyond its scabicidal properties, Eurax is frequently utilized to alleviate discomfort associated with various itchy skin conditions and rashes. Its non-greasy consistency allows for easy application and quick absorption, ensuring comfort throughout the healing process.

Active substance: Crotamiton
SKU: Eurax Categories: ,
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Eurax belongs to a class of topical dermatological agents known as antipruritic and scabicidal medications. It contains the active pharmaceutical ingredient crotamiton at a concentration of 10% in topical cream or lotion formulations.

In the United States, Eurax is approved by the Food and Drug Administration (FDA) as a prescription treatment for scabies infestation and for the symptomatic relief of severe itching (pruritus). Proper application according to medical guidance is necessary to ensure optimal therapeutic outcomes while minimizing skin irritation.

Parameter Specification
Active ingredient Crotamiton 10%
Therapeutic class Scabicide / Antipruritic
Dosage form Topical cream, topical lotion
Route of administration Cutaneous (topical)
Primary purpose Eradication of Sarcoptes scabiei and management of pruritus
Prescription status Prescription only (Rx)

How the drug works

Eurax contains crotamiton, a synthetic agent exhibiting both scabicidal and antipruritic actions. While the precise biochemical mechanism behind its scabicidal efficacy against Sarcoptes scabiei mites remains incompletely defined in scientific literature, the drug exerts a direct toxic effect on the parasite. Beyond its activity against scabies, crotamiton demonstrates a distinct antipruritic effect that relieves skin itching. This anti-itch mechanism operates independently of its parasiticidal property, though it is not primarily an antihistaminic or corticosteroid agent. When applied to affected dermal areas, crotamiton mitigates the urge to scratch, thereby reducing secondary mechanical skin trauma and potential bacterial superinfections.

What it’s used for

In clinical dermatological practice under United States regulations, Eurax is indicated for two primary clinical scenarios. First, it is prescribed for the treatment of scabies (Sarcoptes scabiei) infestation in adult and pediatric populations. Second, it is utilized for the symptomatic control and relief of severe itching associated with various non-parasitic dermatoses. Medical evaluation is essential prior to initiation, as itching can stem from diverse underlying causes including allergic reactions, systemic disorders, or eczema. Using Eurax for off-label cutaneous indications without professional diagnosis is discouraged, as inappropriate topical application can mask symptoms or cause localized skin irritation.

Dosing schedule

Administration of Eurax varies according to the treated condition. For scabies treatment, thorough application is essential: after taking a bath or shower and drying the skin completely, the patient applies cream or lotion from the chin down to the toes, including skin folds, fingernails, and toes. A second application is recommended 24 hours later without washing the body beforehand. A cleansing bath should be performed 48 hours after the second application to remove the medication. For the management of general pruritus, the cream or lotion is gently massaged into affected areas until completely absorbed, typically repeated two to three times daily as directed by the healthcare provider.

How it’s absorbed and eliminated

Systemic absorption of crotamiton following topical application to intact human skin is minimal under standard clinical conditions. Specific quantitative pharmacokinetic metrics such as exact peak plasma concentration ($C_{max}$) and elimination half-life after cutaneous application in humans are not fully established in standard FDA labeling due to extremely low systemic bioavailability. However, available pharmacodynamic data indicate that small amounts of crotamiton absorbed through the dermis undergo hepatic metabolism before being excreted primarily via urine. Extent of absorption can increase if the medication is applied to denuded, inflamed, or broadly damaged skin surfaces or under occlusive dressings, which should generally be avoided unless specifically directed by a clinician.

Compatibility with other medicines

Formal drug interaction studies with topical crotamiton have not been extensively documented in clinical literature. However, combining Eurax with other topical agents, such as topical corticosteroids, retinoids, or harsh antiseptic cleansers, may increase the potential for localized skin irritation, burning, or contact dermatitis. Applying multiple topical formulations simultaneously to the same anatomical site can alter dermal absorption rates or neutralize the active component. Prescribing clinicians should be informed of all topical preparations, OTC medicated washes, and skincare regimens currently utilized by the patient before initiating crotamiton therapy.

Adverse reactions

Topical crotamiton is generally well tolerated, but local adverse cutaneous reactions can occur. The primary side effects reported during clinical use include transient local skin irritation, erythrodermatous rash, pruritus (which may temporarily intensify immediately after application), a mild burning sensation, and allergic contact dermatitis. Hypersensitivity reactions are rare but possible. Systemic adverse effects are highly unlikely when used as directed on intact skin, but accidental oral ingestion or excessive application over large compromised skin areas can result in systemic toxicity, characterized by nausea, vomiting, abdominal pain, and central nervous system depression.

Important precautions

Eurax is strictly for external dermatological use only and must never be applied to mucous membranes, eyes, mouth, or urethral orifices. It should not be applied to acutely inflamed, oozing, or severely excoriated skin. Safety and efficacy in pediatric populations under 18 years of age have not been comprehensively established for all pruritic conditions; caution is advised when treating young infants. For pregnant women, crotamiton is classified under FDA Pregnancy Category C, meaning animal reproduction studies are lacking and it should be administered during pregnancy only if clearly needed. Nursing mothers should exercise caution, avoiding application around the nipple area to prevent infant ingestion.

First days of treatment

During the initial stage of crotamiton therapy for scabies, patients should understand that itching may persist even after the parasitic mites have been successfully eliminated. This post-scabietic itch is an immunological reaction to dead mite proteins rather than active treatment failure. When used for general pruritus, patients often experience temporary relief shortly after application, though complete resolution depends on addressing the primary dermatological condition under medical supervision.

Practical tips

To optimize therapy and prevent reinfection during scabies treatment, all clothing, bedding, and towels used by the patient within three days prior to treatment must be laundered in hot water and dried on a high-heat cycle. Household members and close contacts should be evaluated simultaneously. When applying the formulation, care should be taken to wear gloves or wash hands thoroughly immediately after application, unless treating hands.

Red flags

Patients must discontinue Eurax and seek immediate emergency medical evaluation if they observe signs of severe systemic hypersensitivity or toxicity. Red flag symptoms include swelling of the face, lips, tongue, or throat; significant difficulty breathing; severe widespread hives; or intense dermal inflammation with blistering and skin peeling. Immediate medical care is also required if accidental ingestion occurs.

Storage and expiration

Eurax formulations should be stored at controlled room temperature, ideally between 68°F and 77°F (20°C to 25°C), away from excessive heat, freezing temperatures, and direct moisture. Keep the container tightly closed when not in use and out of reach of children. Do not use the medication past the expiration date printed on the tube or outer packaging.

Common questions

How long does it take for Eurax to relieve itching?

When used for general itching, antipruritic relief typically occurs shortly after application as the cream or lotion is absorbed into the upper skin layers. However, when treating scabies infestation, itching may persist for several weeks after complete mite eradication due to a localized allergic sensitivity to residual mite antigens. If itching remains severe or worsens weeks after completing the prescribed regimen, consult a healthcare provider for evaluation.

Is a single application of Eurax sufficient to treat scabies?

No, the standard FDA-approved treatment regimen for scabies requires two separate applications. The second application must be applied 24 hours after the first without washing off the initial layer. A complete bath or shower to thoroughly wash off the medication is only recommended 48 hours after the second application. Deviating from this schedule may lead to treatment failure.

What should I do if I accidentally get Eurax in my eyes?

If Eurax comes into contact with the eyes, it can cause immediate irritation and inflammation. Flush the eye thoroughly with large amounts of clean, lukewarm water or normal saline solution for several minutes. Keep the eyelid open during flushing. If irritation, redness, pain, or vision alterations persist after thorough rinsing, seek prompt medical attention.

Can Eurax be used on the face or scalp?

Eurax is generally applied from the neck or chin downward for scabies treatment in adults. Application to the face and scalp is typically avoided unless specifically instructed by a dermatologist, as facial skin is more susceptible to irritation and proximity to the eyes and mouth poses accidental exposure risks. In certain pediatric cases under direct medical oversight, scalp application may be specified.

Why is my skin still itching after completing the full scabies treatment?

Persistent itching after scabies treatment is common and does not automatically mean the treatment failed. It is usually caused by an ongoing immunological reaction in the skin to dead scabies mites and their waste products. Dermatologists can recommend supportive treatments, such as mild emollients or topical corticosteroids, to manage post-scabietic itching during recovery.

This text is for informational purposes only and does not constitute individual medical advice.

In accordance with FDA requirements.

Additional information
Dosage

20g

Package

2 tubes

,

3 tubes

,

4 tubes

,

5 tubes

,

6 tubes

,

7 tubes

,

8 tubes

,

9 tubes

,

10 tubes

Ενεργός Ουσία